- Conditions
- ME/CFS, IBS - Irritable Bowel Syndrome
- Interventions
- Floradapt Intensive GI, Placebo
- Drug · Other
- Lead sponsor
- Nova Southeastern University
- Other
- Eligibility
- 45 Years to 70 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Fort Lauderdale, Florida
Source: ClinicalTrials.gov public record
Updated Mar 3, 2025 · Synced May 22, 2026, 12:15 AM EDT